Gladstone Michael 4
4 · Day One Biopharmaceuticals, Inc. · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Gladstone Michael
Director
Transactions
- Award
Director Stock Option (Right to buy Common Stock)
2022-06-21+28,700→ 28,700 totalExercise: $16.29Exp: 2032-06-20→ Common Stock (28,700 underlying)
Footnotes (2)
- [F1]The option vests as to 1/12th of the total shares on each monthly anniversary, beginning on July 21, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]The Reporting Person is a member of Atlas Venture Associates XI, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.